FIELD: medicine.
SUBSTANCE: invention relates to ophthalmology and is intended for differential diagnosis of peripheral retinal haemangioblastoma (RHB) and reactive astrocytic retinal tumor (RART). In the lachrymal fluid of the affected eye, the level of the macrophage inflammatory protein 1α is determined (MIP-1α). If its level is 17.1 pg/l and more, RART is diagnosed, RHB is diagnosed at less than 17.1 pg/ml.
EFFECT: method enables providing reliable, based on objective quantitative indicators, differential diagnosis of RHB and RART with higher diagnostic accuracy and selection of differentiated management approach to patients, their further monitoring, as well as examination for the purpose of detecting tumors of other localizations associated with VHL syndrome.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SURGICAL TREATMENT OF RETINAL ANGIOMATOSIS | 2017 |
|
RU2644543C1 |
| METHOD OF DIAGNOSTICS OF INITIAL JUXTAPAPILLARY CAPILLARY HEMANGIOMA OF RETINA | 2018 |
|
RU2668701C1 |
| METHOD OF SURGICAL TREATMENT OF THE RETINAL HAEMANGIOMA CAPILLARY | 2017 |
|
RU2666690C1 |
| METHOD OF EARLY DIAGNOSIS OF FAMILIAL EXUDATIVE RETINOPATHY IN CHILDREN | 2022 |
|
RU2796894C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR VARIOUS FORMS OF PRIMARY INITIAL RETINOBLASTOMA IN CHILDREN | 2012 |
|
RU2479255C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PRIMARY UVEAL MELANOMA AND LOCALIZED CHOROIDAL HEMANGIOMA USING OPTICAL COHERENT TOMOGRAPHY-ANGIOGRAPHY | 2016 |
|
RU2622380C1 |
| METHOD FOR DETECTING AN INFLAMMATORY COMPONENT THAT PROMOTES TUMOR GROWTH IN INITIAL CHOROIDAL MELANOMA | 2020 |
|
RU2748528C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PROGRESSIVE NEVUS AND CONJUNCTIVAL MELANOMA | 2022 |
|
RU2782134C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PRIMARY MELANOMA AND CHOROID NEVUS | 2018 |
|
RU2689190C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF INITIAL CHOROID MELANOMA AND CHOROID NEVUS BY MEANS OF OPTICAL COHERENT TOMOGRAPHY WITH ANGIOGRAPHIC MODE | 2019 |
|
RU2705419C1 |
